UmarFarooqMD

PubMed

• High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.
  Narendranath Epperla, Adam S Zayac, Daniel J Landsburg, Allison M Bock, Grzegorz S Nowakowski
  Blood Advances. 2024-10-22
• Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy.
  Aung M Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J Inwards
  Transplantation and Cellular Therapy. 2024-10-01
• 1 citations
  Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL.
  Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil, Patrick M Reagan, Umar Farooq
  Blood Advances. 2024-08-27

Abstracts/Posters

• Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Comparison of Two-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel) and SCHOLAR-1 in Patients with Refractory Large B Cell Lymphoma
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Methotrexate and Area Under the Curve Exposure in Patients Receiving MT-R for Primary CNS Lymphoma: A Single Institution Retrospective Study
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Umar Farooq, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all